Phenotyping Rh/Kell and risk of alloimmunization in haematological patients.

MLA

Baía, F., et al. “Phenotyping Rh/Kell and Risk of Alloimmunization in Haematological Patients.” Transfusion Medicine (Oxford, England), vol. 26, no. 1, Feb. 2016, pp. 34–38. EBSCOhost, https://doi.org/10.1111/tme.12271.

APA

Baía, F., Correia, F., Alves, B., Martinez, F., Koch, C., Carneiro, A., & Araújo, F. (2016). Phenotyping Rh/Kell and risk of alloimmunization in haematological patients. Transfusion Medicine (Oxford, England), 26(1), 34–38. https://doi.org/10.1111/tme.12271

Chicago

Baía, F, F Correia, B Alves, F Martinez, C Koch, A Carneiro, and F Araújo. 2016. “Phenotyping Rh/Kell and Risk of Alloimmunization in Haematological Patients.” Transfusion Medicine (Oxford, England) 26 (1): 34–38. doi:10.1111/tme.12271.